Drug interactions between Med-Jec-40 and Stamaril
|Stamaril (yellow fever vaccine)|
Interactions between your drugs
methylPREDNISolone yellow fever vaccine
Applies to: Med-Jec-40 (methylprednisolone) and Stamaril (yellow fever vaccine)
If you are currently being treated or have recently been treated with methylPREDNISolone, you should let your doctor know before receiving yellow fever vaccine. Depending on the dose and length of time you have been on methylPREDNISolone, you may be at risk for developing an infection from the vaccine or have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of methylPREDNISolone therapy. Conversely, if you have recently been vaccinated with yellow fever vaccine, your doctor may choose to postpone treatment with methylPREDNISolone for a few weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
Applies to: Med-Jec-40 (methylprednisolone)
Grapefruit juice may increase the blood levels of certain medications such as methylPREDNISolone. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with methylPREDNISolone. However, if you have been regularly consuming grapefruit or grapefruit juice with the medication, then it is advisable for you to talk with your doctor before changing the amounts of these products in your diet, as this may alter the effects of your medication. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.